These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

341 related items for PubMed ID: 19428628

  • 1. Characterization of cognition alteration across the course of the disease in APP751SL mice with parallel estimation of cerebral Abeta deposition.
    Blanchard J, Decorte L, Noguès X, Micheau J.
    Behav Brain Res; 2009 Jul 19; 201(1):147-57. PubMed ID: 19428628
    [Abstract] [Full Text] [Related]

  • 2. Use of multimetric statistical analysis to characterize and discriminate between the performance of four Alzheimer's transgenic mouse lines differing in Abeta deposition.
    Leighty RE, Nilsson LN, Potter H, Costa DA, Low MA, Bales KR, Paul SM, Arendash GW.
    Behav Brain Res; 2004 Aug 12; 153(1):107-21. PubMed ID: 15219712
    [Abstract] [Full Text] [Related]

  • 3. Progressive cognitive impairment and anxiety induction in the absence of plaque deposition in C57BL/6 inbred mice expressing transgenic amyloid precursor protein.
    Lee KW, Lee SH, Kim H, Song JS, Yang SD, Paik SG, Han PL.
    J Neurosci Res; 2004 May 15; 76(4):572-80. PubMed ID: 15114629
    [Abstract] [Full Text] [Related]

  • 4. One-year longitudinal evaluation of sensorimotor functions in APP751SL transgenic mice.
    Le Cudennec C, Faure A, Ly M, Delatour B.
    Genes Brain Behav; 2008 Feb 15; 7 Suppl 1():83-91. PubMed ID: 18184372
    [Abstract] [Full Text] [Related]

  • 5. Beta-amyloid pathology in the entorhinal cortex of rats induces memory deficits: implications for Alzheimer's disease.
    Sipos E, Kurunczi A, Kasza A, Horváth J, Felszeghy K, Laroche S, Toldi J, Párducz A, Penke B, Penke Z.
    Neuroscience; 2007 Jun 15; 147(1):28-36. PubMed ID: 17499931
    [Abstract] [Full Text] [Related]

  • 6. Intracellular Abeta and cognitive deficits precede beta-amyloid deposition in transgenic arcAbeta mice.
    Knobloch M, Konietzko U, Krebs DC, Nitsch RM.
    Neurobiol Aging; 2007 Sep 15; 28(9):1297-306. PubMed ID: 16876915
    [Abstract] [Full Text] [Related]

  • 7. Lifelong immunization with human beta-amyloid (1-42) protects Alzheimer's transgenic mice against cognitive impairment throughout aging.
    Jensen MT, Mottin MD, Cracchiolo JR, Leighty RE, Arendash GW.
    Neuroscience; 2005 Sep 15; 130(3):667-84. PubMed ID: 15590151
    [Abstract] [Full Text] [Related]

  • 8. Protection against cognitive deficits and markers of neurodegeneration by long-term oral administration of melatonin in a transgenic model of Alzheimer disease.
    Olcese JM, Cao C, Mori T, Mamcarz MB, Maxwell A, Runfeldt MJ, Wang L, Zhang C, Lin X, Zhang G, Arendash GW.
    J Pineal Res; 2009 Aug 15; 47(1):82-96. PubMed ID: 19538338
    [Abstract] [Full Text] [Related]

  • 9. Visuo-spatial learning and memory deficits on the Barnes maze in the 16-month-old APPswe/PS1dE9 mouse model of Alzheimer's disease.
    O'Leary TP, Brown RE.
    Behav Brain Res; 2009 Jul 19; 201(1):120-7. PubMed ID: 19428625
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Intraneuronal Abeta causes the onset of early Alzheimer's disease-related cognitive deficits in transgenic mice.
    Billings LM, Oddo S, Green KN, McGaugh JL, LaFerla FM.
    Neuron; 2005 Mar 03; 45(5):675-88. PubMed ID: 15748844
    [Abstract] [Full Text] [Related]

  • 13. Impaired spatial learning in the APPSwe + PSEN1DeltaE9 bigenic mouse model of Alzheimer's disease.
    Reiserer RS, Harrison FE, Syverud DC, McDonald MP.
    Genes Brain Behav; 2007 Feb 03; 6(1):54-65. PubMed ID: 17233641
    [Abstract] [Full Text] [Related]

  • 14. LMN diet, rich in polyphenols and polyunsaturated fatty acids, improves mouse cognitive decline associated with aging and Alzheimer's disease.
    Fernández-Fernández L, Comes G, Bolea I, Valente T, Ruiz J, Murtra P, Ramirez B, Anglés N, Reguant J, Morelló JR, Boada M, Hidalgo J, Escorihuela RM, Unzeta M.
    Behav Brain Res; 2012 Mar 17; 228(2):261-71. PubMed ID: 22119712
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Age-related impairments in operant DMTP performance in the PS2APP mouse, a transgenic mouse model of Alzheimer's disease.
    Woolley ML, Ballard TM.
    Behav Brain Res; 2005 Jun 20; 161(2):220-8. PubMed ID: 15922048
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Mice expressing the Swedish APP mutation on a 129 genetic background demonstrate consistent behavioral deficits and pathological markers of Alzheimer's disease.
    Rustay NR, Cronin EA, Curzon P, Markosyan S, Bitner RS, Ellis TA, Waring JF, Decker MW, Rueter LE, Browman KE.
    Brain Res; 2010 Jan 22; 1311():136-47. PubMed ID: 19944081
    [Abstract] [Full Text] [Related]

  • 20. Powerful beneficial effects of macrophage colony-stimulating factor on beta-amyloid deposition and cognitive impairment in Alzheimer's disease.
    Boissonneault V, Filali M, Lessard M, Relton J, Wong G, Rivest S.
    Brain; 2009 Apr 22; 132(Pt 4):1078-92. PubMed ID: 19151372
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.